Purchases and Sales Made in Q1 2023 in Aerovate Therapeutics, Inc. (AVTE)
This table provides information about the institutional ownership of Aerovate Therapeutics, Inc. (AVTE) during Q1 2023. The information is specifically focused on institutions that hold shares of Aerovate Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-13.5K- 45.89% |
$259K - $375K
|
16K
$40.2K
|
|
|
May 15, 2023
Q1 2023
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-41K- 44.94% |
$786K - $1.14M
|
50.2K
$127K
|
|
|
Nov 08, 2023
Q1 2023
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-41K- 44.94% |
$786K - $1.14M
|
50.2K
$127K
|
|
|
May 15, 2023
Q1 2023
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-43.9K- 29.68% |
$842K - $1.22M
|
104K
$262K
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-102K- 83.12% |
$1.96M - $2.84M
|
20.8K
$52.4K
|
|
|
May 15, 2023
Q1 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-106K- 60.51% |
$2.03M - $2.93M
|
69.1K
$174K
|
|
|
May 15, 2023
Q1 2023
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-395K- 20.2% |
$7.58M - $11M
|
1.56M
$3.94M
|